Reduced expression of plakoglobin correlates with adverse outcome in patients with neuroblastoma

American Journal of Pathology

Volumn 159, Issue 1, 2001, Pages 43-49

  Amitay, Raya ^a   Nass, Dvora ^a   Meitar, Dafna ^a,b   Goldberg, Iris ^a   Davidson, Ben ^a,d   Trakhtenbrot, Luba ^a   Brok Simoni, Frida ^a   Ben Ze'ev, Avri ^c   Rechavi, Gideon ^a,b   Kaufmann, Yael ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CADHERIN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; DESMOPLAKIN; PLAKOGLOBIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CANCER STAGING; CELL CULTURE; CHILD; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; METABOLISM; MORTALITY; NEUROBLASTOMA; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; SURVIVAL; WESTERN BLOTTING;

BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CHILD; CHILD, PRESCHOOL; CYTOSKELETAL PROTEINS; DESMOPLAKINS; GAMMA CATENIN; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; NEOPLASM STAGING; NEUROBLASTOMA; SURVIVAL ANALYSIS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0035408818     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61671-9     Document Type: Article

References (37)

1. Cowin P, Karpell HP, Franke WW, Tamkun J, Hynes RO: Plakoglobin: a protein common to deferent kinds of intracellular adhering junction. Cell 1986, 46:1063-1073
2. Ben-Ze'ev A, Geiger B: Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer. Curr Opin Cell Biol 1998, 10:629-639
3. Bullions LC, Levine AJ: The role of β-catenin in cell adhesion, signal transduction, and cancer. Curr Opin Oncol 1998, 10:81-87
4. Hata K, Takeichi M: Expression of N-cadherin molecules associated with early morphogenetic events in chick development. Nature 1986, 320:447-449
5. Matsunaga M, Hata K, Nagafuchi A, Takeichi M: Guidance of optic nerve fibers by N-cadherin adhesion molecules. Nature 1988, 334: 62-64
6. Akitaya T, Bronner-Fraser M: Expression of cell adhesion molecules during initiation and cessation of neural crest cell migration. Dev Dyn 1992, 194:12-20
7. Kemler R: From cadherins to catenins cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 1993, 9:317-321
8. Uchida N, Honjo Y, Johnson KR, Wheelock MJ, Takeichi M: The catenin/cadherin adhesion system is localized in synaptic junctions bordering transmitter release zones. J Cell Biol 1996, 135:767-779
9. Zhurinsky J, Shtutman M, Ben-Ze'ev A: Plakoglobin and β-catenin: protein interactions, regulation and biological roles. J Cell Science 2000, 113:3127-3139
10. Papkoff J, Rubinfeld B, Schryver B, Polakis P: Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol Cell Biol 1996, 16:2128-2134
11. Korinek V, Barker N, Morin P, van Wichen D, de Weger R, Kinzler K, Vogelstein B, Clevers H: Constitutive transcriptional activation by a β-calenin-TcF complex in APC-/- colon carcinoma Science 1997, 275:1784-1787
12. Morin P, Sparks A, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler K: Activation of β-catenin-TcF signaling in colon cancer by mutations in β-catenin or APC. Science 1997, 275:1787-1790
13. Reifer M: β-catenin as an oncogene: the smoking gun. Science 1997, 275:1752-1753
14. Simcha I, Geiger B, Yehuda-Levenberg S, Salomon D, Ben-Ze'ev A: Suppression of tumorigenicity by plakoglobin: augmenting effect of N-cadherin. J Cell Biol 1996, 133:199-209
15. Buchner A, Oberneder R. Riesenberg R, Keiditsch E, Hofstetter A: Expression of plakoglobin in renal cell carcinoma. Anticancer Res 1998, 18:4231-4235
16. Nakanisho Y, Ochiai A, Akimoto S, Kato H, Watanabe H, Tachimori Y, Yamamoto S, Hirohashi S: Expression of E-cadherin, α-catenin, β-catenin ana plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology 1997, 54:158-165
17. Tada H, Hatoko M, Tanaka A, Kuwahara M, Muramatsu T: Expression of desmoglein I and plakoglobin in skin carcinomas. J Cutan Pathol 2000, 27:24-29
18. Aberle H, Bierkamp C, Torchard D, Serova O, Wagner T, Natt E, Wirsching J, Heidkamper C, Montagna M, Lynch T, Lenior GM, Scherer G, Fuenteun J, Kemler R: The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc Natl Acad Sci USA 1995, 92:6384-6388
19. Ambros IM, Zellner A, Roald B, Amann G, Ladenstein R, Printz D, Gadner H, Ambros PF: Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N Engl J Med 1996, 334: 1505-1511
20. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313: 1111-1116
21. Birchmeier W, Behrens J: Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994, 1198:11-26
22. Cohn SL, Salwen H, Quasney MW, Ikegaki N, Cowan JM, Herst CV, Kennet RH, Rosen ST, DiGiuseppe JA, Brodeur GM: Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification. Oncogene 1990, 5:1821-1827
23. Foley J, Cohn SL, Salwen HR, Chagnovich D, Cowan J, Mason KL, Parysek LM : Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line. Cancer Res 1991, 52:6338-6345
24. Wollman Y, Shahar I, Goldshtein M, Leibovici J: Malignant phenotype correlating with drug resistance in two human neuroblastoma cell lines. J Neurooncol 1994, 19:123-129
25. Goldberg I, Davidson B, Lerner-Geva L, Gotlieb WH, Ben-Baruch G. Novikov I, Kopolovic J: Expression of extracellular matrix proteins in cervical squamous cell carcinoma - a clinicopathological study J Clin Pathol 1998, 51:781-785
26. Johnson KR, Lewis JE, Li D, Wahl J, Soler AP, Knudsen KA, Wheelock MJ: P- and E-cadherin are in separate complexes in cells expressing both cadherins. Exp Cell Res 1993, 207:252-260
27. Knudsen KA, Soler AP, Johnson KR, Wheelock MJ: Interaction of α-actinin with the cadherin/catenin cell-cell adhesion complex via α-catenin. J Cell Biol 1995, 130:67-77
28. Shimada H, Ambras IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP: The international neuroblastoma pathology classification (the Shimada system). Cancer 1999, 86:364-372
29. Shimono R, Matsubara S, Takamatsu H, Fukushige T, Ozawa M: The expression of cadherins in human neuroblastoma cell lines and clinical tumors. Anticancer Res 2000, 20:917-923
30. Shinoura N, Paradies NE, Warnick RE, Chen H, Larson JJ, Simon M Lynch RA, Kanai Y, Hirohashi S, Hemperly JJ, Menon AG, Brackenbury R: Expression of N-cadherin and α-catenin in astrocytomas and glioblastomas. Br J Cancer 1995, 72:627-633
31. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ: N-cadherin promotes motility n human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999, 147:631-644
32. Hazan RB, Philips GR, Qiao RF, Norton L, Aaronson SA: Exogenous expression of N-cadherin in breast cancer cells, induces cell migration, invasion and metastasis. J Cell Biol 2000, 148:779-790
33. Depondt J, Shabana AH, Florescue ZS, Gehanno P, Forest N: Down-regulation of desmosomal molecules in oral and pharyngeal squamous cell carcinomas as a marker for tumor growth and distant metastasis. Eur J Oral Sci 1999, 107:183-193
34. Williams BO, Banish GD, Klymkowsky MW, Varmus HE: A comparative evaluation of beta-catenin and plakoglobin signaling activity. Oncogene 2000, 19:5720-5728
35. Zhurinsky J, Shtutman M, Ben-Ze'ev A: Differential mechanisms of LEF/TCF-dependent transcriptional activation of β-catenin and plakoglobin. Mol Cell Biol 2000, 20:4238-4252
36. Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG: Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 1997, 150:81-89
37. Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson ADJ, Plantaz D, Meddeb M Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F: Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 1999, 340:1954-1961